Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Reviva Announces Positive Full Dataset for 1-Year Phase 3 RECOVER Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia
-
Prepare now: Homeowners along coast, inland urged to strengthen homes with IBHS Hurricane Ready guidance
-
Big Names & Fresh Faces Headline Rogers Sports & Media’s Canadian Originals Slate for HGTV and Food Network
-
Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine
-
Assured Data Protection launches Rubrik MSP service in France
-
Altair to Showcase AI-Powered Engineering, Smart Manufacturing, and Connected Aerospace Solutions at Paris Air Show 2025
-
Forward Air Shareholders Recommended to Vote AGAINST Three Unfit Legacy Directors at 2025 Annual Meeting by ISS
-
Acuren Corporation Announces Upcoming Participation in the Baird 2025 Global Consumer, Technology & Services Conference
-
Hyundai Named Top Mass-Market Brand in the J.D. Power 2025 U.S. OEM EV App Report for Second Year in a Row
-
Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic
-
Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO Annual
-
Small Door Veterinary Opens in Virginia With New McLean Location
-
Cyngn Launches Dealer Portal to Facilitate the Scaled Expansion of Its Dealer Network
-
Software Launches for SCIEX OS Ecosystem to Help Scientists Accelerate Discoveries and Streamline Lab Operations
-
SCIEX and Evosep expand access to standardized proteomics for Pharma and Biotech with new reseller agreement
-
Alithya acquires eVerge, adding Salesforce expertise, deepening Oracle and AI capabilities and expanding smart shoring in India
-
AGI Announces Board Chair and Committee Chair Appointments
-
Bruker Unveils New proteoElute™ nanoLC System and PepSep® Advanced nLC Columns for up to 50% Improved Peptide Sensitivity
-
IsoEnergy Announces Launch of At-The-Market Equity Program
-
Latus Bio Strengthens Executive Team with Appointments of Ainslie Little as COO and Katie Hewitt as interim CBO
-
Medica Launches in St. Louis, Bringing First Nonprofit Health Coverage and Local Partnerships to the Region
-
SERENA-6 Phase III Trial Demonstrates Clinical Value of Guardant360 CDx Test to Detect Emergence of Endocrine Resistance and Inform a Switch in Therapy Before Radiological Disease Progression in Advan
-
Sierra Metals Calls Annual General and Special Meeting of Shareholders
-
Warby Parker Announces Participation in the Baird Global Consumer, Technology & Services Conference
-
Plum Wins Gold at the 5th Annual 2025 Globee® Awards for Disruptors
-
Elevate Windows and Doors Appoints Phil Mahaney as General Manager
-
SCIEX Sets a New Standard in Accurate Mass Quantitation With the ZenoTOF 8600 System and New Software Collaborations
-
Alkermes Highlights Data From Psychiatry Portfolio at Spring 2025 Scientific Conferences
-
KalVista Pharmaceuticals Medical Congress Presentations Highlight Potential of Sebetralstat to Redefine Hereditary Angioedema Management
-
ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis
-
Lenovo and Bellevue University Team Up to Offer Supply Chain and Logistics Education to Deliver “Smarter Technology for All”
-
NervGen Pharma Reports Positive Topline Data from the Chronic Cohort of its Phase 1b/2a Clinical Trial Evaluating NVG-291 in Spinal Cord Injury
-
Interim Results from Ongoing Phase 2 COURAGE Trial Confirm Potential to Improve the Quality of Semaglutide (GLP-1 receptor agonist)-induced Weight Loss by Preserving Lean Mass
-
Coda Octopus Group Sets Fiscal Second Quarter 2025 Earnings Conference Call for Monday, June 16, 2025, at 10 a.m. Eastern Time
-
Leading Independent Proxy Advisor ISS Recommends that Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees; REJECTS Apollo’s Arguments and Director Slate
-
Aura Minerals Agrees to Acquire the Mineração Serra Grande Gold Mine in Goiás, Brazil
-
ConnectOne Bancorp, Inc. Completes Merger With the First of Long Island Corporation
-
Vanguard Food LP Announces Closing of Transaction to Create Emerging Leader in North American Produce Industry
-
Village Farms International Announces Closing of Transaction to Privatize its Fresh Produce Business
-
Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress
-
Nokia and Andorix partner to accelerate Private 5G and Edge Solutions in North American real estate market
-
Kymera Therapeutics Announces Positive First-in-Human Results from Phase 1 Healthy Volunteer Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader
-
Denodo University Challenge Now Open: Data and AI for Real-World Impact
-
Instil Bio Announces Appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical Officer
-
Recludix Pharma Announces Development Candidate Nomination of First-in-Class Oral STAT6 Inhibitor for Inflammatory Diseases and Achievement of Significant Milestone Under Collaboration with Sanofi
-
CW Petroleum Corp (OTCQB: CWPE) Shareholder Update 6/2/2025
-
Outlook Therapeutics® Announces Commercial Launch of LYTENAVA™ (bevacizumab gamma) in Germany and the UK for the Treatment of Wet AMD
-
5E Advanced Materials to Participate in the MicroCap Rodeo Conference on June 4, 2025
-
ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage
-
Snipp Interactive Reports Q1 2025 Financial Results - Company to Hold Investor Conference Call on June 3, 2025
